Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CardiAMP Cell Therapy (BCDA-01) / BioCardia
NCT02438306: CardiAMP™ Cell Therapy for Heart Failure Trial	Active, not recruiting	3	125	Canada, US	Autologous cell therapy, Sham	BioCardia, Inc.	Heart Failure, Systolic	12/24	12/26
NCT06258447: CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction	Recruiting	N/A	250	US	Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system	BioCardia, Inc.	Ischemic Heart Failure	04/27	04/29
CardiALLO (BCDA-03) / BioCardia
NCT05925608: Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells	Enrolling by invitation	1/2	39	US	CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs), Diagnostic Catheterization	BioCardia, Inc.	Heart Failure, Systolic	07/25	07/25
CardiAMP Cell Therapy (BCDA-02) / BioCardia
CardiAMP CMI, NCT03455725: CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial	Recruiting	N/A	343	US	CardiAMP Cell Therapy System, Sham Treatment	BioCardia, Inc.	Refractory Angina, Chronic Myocardial Ischemia	07/25	12/26
BDCA-04 / BioCardia
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
CardiAMP Cell Therapy (BCDA-01) / BioCardia
NCT02438306: CardiAMP™ Cell Therapy for Heart Failure Trial	Active, not recruiting	3	125	Canada, US	Autologous cell therapy, Sham	BioCardia, Inc.	Heart Failure, Systolic	12/24	12/26
NCT06258447: CardiAMP Heart Failure II Trial for Patients With Ischemic Heart Failure With Reduced Ejection Fraction	Recruiting	N/A	250	US	Autologous bone marrow mononuclear cells processed / delivered using the CardiAMP cell therapy system	BioCardia, Inc.	Ischemic Heart Failure	04/27	04/29
CardiALLO (BCDA-03) / BioCardia
NCT05925608: Clinical Trial of Human Allogenic Culture-expanded Bone Marrow-derived Mesenchymal Stem Cells	Enrolling by invitation	1/2	39	US	CardiALLO™ Human Allogenic Culture-expanded Bone marrow-derived Mesenchymal Stem Cells (hMSCs), Diagnostic Catheterization	BioCardia, Inc.	Heart Failure, Systolic	07/25	07/25
CardiAMP Cell Therapy (BCDA-02) / BioCardia
CardiAMP CMI, NCT03455725: CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial	Recruiting	N/A	343	US	CardiAMP Cell Therapy System, Sham Treatment	BioCardia, Inc.	Refractory Angina, Chronic Myocardial Ischemia	07/25	12/26
BDCA-04 / BioCardia
No trials found